272 related articles for article (PubMed ID: 19665938)
1. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
Farrar JT; Pritchett YL; Robinson M; Prakash A; Chappell A
J Pain; 2010 Feb; 11(2):109-18. PubMed ID: 19665938
[TBL] [Abstract][Full Text] [Related]
2. Estimation of minimum clinically important difference for pain in fibromyalgia.
Mease PJ; Spaeth M; Clauw DJ; Arnold LM; Bradley LA; Russell IJ; Kajdasz DK; Walker DJ; Chappell AS
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):821-6. PubMed ID: 21312349
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
Arnold LM; Zhang S; Pangallo BA
Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
[TBL] [Abstract][Full Text] [Related]
6. Pain response profile of patients with fibromyalgia treated with duloxetine.
Bradley LA; Wohlreich MM; Wang F; Gaynor PJ; Robinson MJ; D'Souza DN; Mease PJ
Clin J Pain; 2010; 26(6):498-504. PubMed ID: 20551724
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
8. What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine.
Hudson JI; Arnold LM; Bradley LA; Choy EH; Mease PJ; Wang F; Ahl J; Wohlreich MM
J Rheumatol; 2009 Nov; 36(11):2517-22. PubMed ID: 19833743
[TBL] [Abstract][Full Text] [Related]
9. An Assessment of Clinically Important Differences on the Worst Pain Severity Item of the Modified Brief Pain Inventory in Patients with Diabetic Peripheral Neuropathic Pain.
Marcus J; Lasch K; Wan Y; Yang M; Hsu C; Merante D
Pain Res Manag; 2018; 2018():2140420. PubMed ID: 30140328
[TBL] [Abstract][Full Text] [Related]
10. Responsiveness of efficacy endpoints in clinical trials with over the counter analgesics for headache.
Aicher B; Peil H; Peil B; Diener HC
Cephalalgia; 2012 Oct; 32(13):953-62. PubMed ID: 22763497
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
Russell JM; Weisberg R; Fava M; Hartford JT; Erickson JS; D'Souza DN
Depress Anxiety; 2008; 25(7):E1-11. PubMed ID: 17587217
[TBL] [Abstract][Full Text] [Related]
12. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.
Farrar JT; Young JP; LaMoreaux L; Werth JL; Poole MR
Pain; 2001 Nov; 94(2):149-158. PubMed ID: 11690728
[TBL] [Abstract][Full Text] [Related]
13. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Fishbain DA; Hall JA; Risser RC; Gonzales JS
Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
[TBL] [Abstract][Full Text] [Related]
14. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
[TBL] [Abstract][Full Text] [Related]
15. Minimal clinically important change for pain intensity and disability in patients with nonspecific low back pain.
Kovacs FM; Abraira V; Royuela A; Corcoll J; Alegre L; Cano A; Muriel A; Zamora J; del Real MT; Gestoso M; Mufraggi N
Spine (Phila Pa 1976); 2007 Dec; 32(25):2915-20. PubMed ID: 18246018
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
Mease PJ; Russell IJ; Kajdasz DK; Wiltse CG; Detke MJ; Wohlreich MM; Walker DJ; Chappell AS
Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
[TBL] [Abstract][Full Text] [Related]
17. Neck Disability Index, short form-36 physical component summary, and pain scales for neck and arm pain: the minimum clinically important difference and substantial clinical benefit after cervical spine fusion.
Carreon LY; Glassman SD; Campbell MJ; Anderson PA
Spine J; 2010 Jun; 10(6):469-74. PubMed ID: 20359958
[TBL] [Abstract][Full Text] [Related]
18. Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia.
Wang F; Ruberg SJ; Gaynor PJ; Heinloth AN; Arnold LM
J Pain; 2011 Oct; 12(10):1088-94. PubMed ID: 21763211
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
[TBL] [Abstract][Full Text] [Related]
20. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
Ziegler D; Pritchett YL; Wang F; Desaiah D; Robinson MJ; Hall JA; Chappell AS
Diabetes Care; 2007 Mar; 30(3):664-9. PubMed ID: 17327338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
